PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 3 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Isolated compounds (including termitomenins A-E) exhibited anti-inflammatory activities by inhibiting NO production in vitro [PMID:32209392].
Hydrolyzable tannins from the plant exhibited alpha-glucosidase inhibitory activities in vitro [PMID:34114172].
Evidence summary
PubMed sources
- 1.PMID: 33892063 (2021) — Multiple in vitro biological effects of phenolic compounds from Terminalia chebula var. tomentella. · Journal of ethnopharmacology
- 2.PMID: 32209392 (2020) — Termitomenins A-E: Five new lignans from Terminalia chebula var. tomentella (Kurz) C. B. Clarke. · Fitoterapia
- 3.PMID: 34114172 (2021) — Termitomenins F and G, Two New Lignan Glucosides from Terminalia chebula var. tomentella (Kurz) C. B. Clarke. · Natural products and bioprospecting